Odintropin 150 IU
Odintropin is a brand of recombinant human growth hormone (somatropin), commonly used as a treatment for growth hormone deficiency (GHD) in both children and adults. The “150 IU” version typically comes in a kit containing five vials of 30 IU each (totaling 150 IU), along with vials of diluent for reconstitution.
Composition & Formulation
Active Ingredient: Somatropin (human growth hormone)
Packaged as lyophilized (freeze-dried) powder in vials, plus separate diluent for reconstitution
A typical kit includes multiple vials to allow for dosing flexibility.
Odintropin 150 IU Mechanism of Action
Somatropin works by binding to growth hormone receptors in target tissues, stimulating the release of insulin-like growth factor 1 (IGF-1) from the liver, which promotes cell growth, bone formation, and protein synthesis.
Indications
Odintropin is indicated for:
Children with growth hormone deficiency (GHD) to improve growth velocity and final adult height
Adults with GHD, where it can improve body composition, bone density, and quality of life
Also used in conditions like Turner syndrome, Prader–Willi syndrome, chronic renal insufficiency, and idiopathic short stature in children.
Dosage & Administration
Route: Subcutaneous (under the skin) injection, usually administered by healthcare professionals
Children: Around 0.025–0.05 mg/kg/day, adjusted based on growth response
Adults: Initial dosing typically in the range of 0.2–0.5 mg/day, with gradual increases up to 1.0 mg/day based on IGF-1 monitoring
Some sources convert these values to international units (IU)—for instance, a daily dose of 4–10 IU/day is mentioned
Side Effects & Precautions Odintropin 150 IU
Common side effects may include:
Injection site reactions (redness, swelling)
Headache, joint or muscle pain, fluid retention (edema)
Metabolic effects such as insulin resistance or changes in lipid profile
Rare but serious effects: increased intracranial pressure, progression of scoliosis, potential increased risk of malignancy
Precautions:
Contraindicated in patients with active malignancy, untreated intracranial lesions, or hypersensitivity. Requires cautious monitoring in individuals with diabetes or at risk of glucose intolerance.
Odintropin 150 IU Storage Guidelines
Store refrigerated at 2–8 °C
Do not freeze
Protect from light
Keep securely stored and handle with aseptic technique to maintain sterility
To enhance discoverability, consider including terms like:
Somatropin injection
Human growth hormone therapy
Odintropin dosage and side effects
Summary Table
| Feature | Details |
|---|---|
| Product | Odintropin 150 IU (somatropin, recombinant hGH) |
| Formulation | Lyophilized powder + diluent; 5 vials × 30 IU |
| Use | Treatment of growth hormone deficiencies and related conditions |
| Dosage | Children: ~0.025–0.05 mg/kg/day; Adults: ~0.2–1.0 mg/day |
| Side Effects | Injection site pain, edema, headache, metabolic changes, rare serious effects |
| Storage | Refrigerate 2–8 °C, do not freeze, protect from light; sterile handling |
Recombinant human growth hormone (rhGH) is a lab-made version of natural hGH used to treat growth disorders in children and metabolic deficiencies in adults. It improves growth, muscle, bone strength, and metabolism, but requires medical supervision due to potential risks.
Reviews
There are no reviews yet.